Cantor Fitzgerald Comments on Aurinia Pharmaceuticals Inc.'s FY2024 Earnings (NASDAQ:AUPH)

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) – Equities research analysts at Cantor Fitzgerald issued their FY2024 earnings estimates for shares of Aurinia Pharmaceuticals in a report issued on Tuesday, July 11th. Cantor Fitzgerald analyst O. Brayer forecasts that the biotechnology company will post earnings of ($0.39) per share for the year. The consensus […]

Related Keywords

Blackrock ,Nova Scotia ,Canada ,United States ,Davidrw Jayne , ,Aurinia Pharmaceuticals ,Armistice Capital ,Aurinia Pharmaceuticals Company Profile ,Otsuka Pharmaceutical Co Ltd ,Cantor Fitzgerald ,Institutional Trading Of Aurinia Pharmaceuticals ,Nasdaq ,Securities Exchange Commission ,Aurinia Pharmaceuticals Inc ,Insider Activity At Aurinia Pharmaceuticals ,Royal Bank ,Blackrock Inc ,Aurinia Pharmaceuticals Stock Down ,News Ratings For Aurinia Pharmaceuticals Daily ,Bellevue Group ,Free Report ,Aurinia Pharmaceutical ,Get Free Report ,Pharmaceuticals Stock Down ,Street Corp ,Exchange Commission ,Pharmaceuticals Inc ,Aurinia Pharmaceuticals Daily ,